日付 | 受信時刻 | ニュースソース | 見出し | コード | 企業名 |
2020/07/06 | 22 : 16 | InvestorsHub NewsWire | The Rapid Rise of Alternet Systems, Inc. (OTCMKTS: ALYI) | USOTC:DECN | Decision Diagnostics Corporation (CE) |
2020/03/05 | 00 : 15 | InvestorsHub NewsWire | DECN Fills in the Gaps, Adds to Knowledge Base for its GenViro Coronavirus (Covid19) Multi-Dimensional Diagnostic Methodology | USOTC:DECN | Decision Diagnostics Corporation (CE) |
2019/05/09 | 22 : 55 | InvestorsHub NewsWire | DECN SETS PLAN TO MAKE UPCOMING PATENT APPEAL HEARING AND MEDIATION WITH JOHNSON & JOHNSON A FOUNDATION FOR SUBSTANTIAL RECOV... | USOTC:DECN | Decision Diagnostics Corporation (CE) |
2019/04/04 | 23 : 00 | InvestorsHub NewsWire | DECN HAILS COMPLETION OF ITS GENULTIMATE! TBG PANACEA SYSTEM, 3RD PARTY TESTING TO BEGIN IN 7 DAYS, CLINICAL TRIALS IN MAY | USOTC:DECN | Decision Diagnostics Corporation (CE) |
2019/03/19 | 05 : 35 | Edgar (US Regulatory) | Withdrawal of Offering Statement Under Regulation a (1-a-w) | USOTC:DECN | Decision Diagnostics Corporation (CE) |
2019/02/26 | 05 : 34 | Edgar (US Regulatory) | Amended Registration a Offering Under the Securities Act of 1933 (1-a/a) | USOTC:DECN | Decision Diagnostics Corporation (CE) |
2019/01/31 | 00 : 00 | InvestorsHub NewsWire | DECN SUBSIDIARY RECEIVES 510K SUBMISSION AND "K" NUMBERS FROM FDA CDRH FOR ITS GENCHOICE! TEST STRIP AT THE CLOSE OF THE | USOTC:DECN | Decision Diagnostics Corporation (CE) |
2019/01/17 | 23 : 55 | InvestorsHub NewsWire | DECN DISCUSSES ITS GENULTIMATE! TBG SYSTEM, OFFERING ELITE PERFORMANCE AND PREMIER UPGRADE PATH FOR 4+ MILLION LIFESCAN USERS | USOTC:DECN | Decision Diagnostics Corporation (CE) |
2018/12/20 | 00 : 03 | InvestorsHub NewsWire | DECN SUBSIDIARIES APPEAL NEVADA DISTRICT COURT RULING TO U.S. COURT OF APPEALS FOR THE FEDERAL CIRCUIT (the patent court) | USOTC:DECN | Decision Diagnostics Corporation (CE) |
2018/12/17 | 23 : 55 | InvestorsHub NewsWire | DECN ENGAGES SECOND KOREAN MANUFACTURING PARTNER TO RAISE ITS FACTORY CAPACITY TWO MILLION BOXES OF "GEN" TEST STRIPS ANNUALLY | USOTC:DECN | Decision Diagnostics Corporation (CE) |
2018/12/12 | 00 : 00 | InvestorsHub NewsWire | DECN RELEASES ITS STRATEGIC IP AND PRODUCT DEVELOPMENT INTRODUCTION PLAN WITH A SUMMARY OF 2018 ACHIEVEMENTS & 2019 EXPECTATI... | USOTC:DECN | Decision Diagnostics Corporation (CE) |
2018/12/05 | 00 : 00 | InvestorsHub NewsWire | DECN RECEIVES CLINICAL TRIALS REPORT, ANTICIPATES FILING ITS FDA 510K APPLICATION FOR ITS GENCHOICE! TEST STRIP ON 12/21/2018 | USOTC:DECN | Decision Diagnostics Corporation (CE) |
2018/11/27 | 23 : 50 | InvestorsHub NewsWire | DECN CEO KEITH M. BERMAN IS INTERVIEWED BY PRESTIGIOUS WALL STREET REPORTER WHO DESCRIBE COMPANY & PRODUCTS AS "GAME CHANGER" | USOTC:DECN | Decision Diagnostics Corporation (CE) |
2018/11/06 | 23 : 55 | InvestorsHub NewsWire | DECN RECEIVES COMPLETED CLINICAL TRIAL DATA, CHARTS AND SPREADSHEETS ESSENTIAL FOR ITS IMMINENT GENCHOICE! TEST STRIP | USOTC:DECN | Decision Diagnostics Corporation (CE) |
2018/10/30 | 22 : 33 | InvestorsHub NewsWire | DECN SET TO APPEAL UNFAIR RULING IN COURT'S TERMINATION OF THE DECN CASE AGAINST INDUSTRY GIANT JOHNSON & JOHNSON | USOTC:DECN | Decision Diagnostics Corporation (CE) |
2018/10/29 | 23 : 15 | InvestorsHub NewsWire | DECN TO COMMENT AND PROVIDE ATTACK PLAN AFTER RECENT COURT RULING | USOTC:DECN | Decision Diagnostics Corporation (CE) |
2018/09/13 | 23 : 00 | InvestorsHub NewsWire | DECN BOARD OF DIRECTORS IN FINAL REVIEW OF PRELIMINARY FINANCING AGREEMENT FOR $4.75 MILLION INVESTMENT | USOTC:DECN | Decision Diagnostics Corporation (CE) |
2018/09/06 | 23 : 00 | InvestorsHub NewsWire | DECN ANNOUNCES MAJOR STEP AHEAD WITH OFFERING STATEMENT | USOTC:DECN | Decision Diagnostics Corporation (CE) |
2018/08/01 | 21 : 06 | Edgar (US Regulatory) | Registration a Offering Under the Securities Act of 1933 (1-a) | USOTC:DECN | Decision Diagnostics Corporation (CE) |
2018/04/18 | 22 : 51 | InvestorsHub NewsWire | Decision Diagnostics (DECN) Contemplates Additional Legal Actions Against Longtime Adversary Johnson & Johnson (JNJ) | USOTC:DECN | Decision Diagnostics Corporation (CE) |
2018/03/28 | 04 : 05 | InvestorsHub NewsWire | DECISION DIAGNOSTICS DISCUSSES CULMINATION OF PATENT CASE AGAINST J&J BASED ON THE FEDERAL DOCTRINE OF EQUIVALENTS | USOTC:DECN | Decision Diagnostics Corporation (CE) |
2018/03/21 | 22 : 40 | InvestorsHub NewsWire | DECISION DIAGNOSTICS' PANACEA GENPRECIS! PRODUCT MOVES INTO PRE-PRODUCTION, 1ST ROUND CLINICAL TRIALS TO BEGIN IN THE ~30 DAYS | USOTC:DECN | Decision Diagnostics Corporation (CE) |
2018/03/13 | 22 : 50 | InvestorsHub NewsWire | Decision Diagnostics' Fundamental Genchoice! Test Strip Moves into Clinical Trials in Advance of 510K Filing with FDA | USOTC:DECN | Decision Diagnostics Corporation (CE) |
2018/01/03 | 23 : 55 | InvestorsHub NewsWire | DECN ANNOUNCES 2018 BUSINESS FOCUS -- NEW PRODUCTS, CONCLUSION TO J&J LITIGATION & NEW ADDITION OF HYBRID PRIVATE LABEL MODEL | USOTC:DECN | Decision Diagnostics Corporation (CE) |
2017/12/21 | 00 : 15 | InvestorsHub NewsWire | DECISION DIAGNOSTICS PROVIDES ADDITIONAL COMMENTARY ABOUT ITS NEW GENACCORD!™, DIABETIC TEST STRIP | USOTC:DECN | Decision Diagnostics Corporation (CE) |
2017/12/21 | 00 : 15 | InvestorsHub NewsWire | DECISION DIAGNOSTICS PROVIDES ADDITIONAL COMMENTARY ABOUT ITS NEW GENACCORD!™, DIABETIC TEST STRIP | USOTC:DECN | Decision Diagnostics Corporation (CE) |
2017/12/21 | 00 : 15 | InvestorsHub NewsWire | DECISION DIAGNOSTICS PROVIDES ADDITIONAL COMMENTARY ABOUT ITS NEW GENACCORD!™, DIABETIC TEST STRIP | USOTC:DECN | Decision Diagnostics Corporation (CE) |
2017/12/15 | 00 : 00 | InvestorsHub NewsWire | DECN ANNOUNCES IT'S NEW GENACCORD!™, DIABETIC TEST STRIP WITH FIRST USE OF ITS GENPRECIS!™ FULL SPREAD ELECTRODE ... | USOTC:DECN | Decision Diagnostics Corporation (CE) |
2017/11/01 | 23 : 15 | InvestorsHub NewsWire | DECISION DIAGNOSTICS CORP. (DECN) OFFERS UPDATE ON LEGAL PROCEEDINGS, OUTCOMES, HISTORY & SYNOPSIS ON ITS STRATEGIC SUIT VS. ... | USOTC:DECN | Decision Diagnostics Corporation (CE) |
2017/10/18 | 23 : 10 | InvestorsHub NewsWire | DECISION DIAGNOSTICS CORP FURTHER DISCUSSES ITS PANACEA GENPRECIS!™ PRODUCT | USOTC:DECN | Decision Diagnostics Corporation (CE) |